4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-099124
Chief Operating Officer sold 2,910 shares at an average $45.12 ($131,304)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HIGH SUSANNA GATTI Chief Operating Officer | 2024-08-19 | Sale 10b5-1 | −2,582 | $45.01 | $116,216 | 146,210 | D |
| HIGH SUSANNA GATTI Chief Operating Officer | 2024-08-19 | Sale 10b5-1 | −328 | $46.00 | $15,088 | 145,882 | D |
| Open-market sales · 2,910 sh · avg $45.12 · $131,304 | |||||||
Loading xslF345X05/ownership.xml…